Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca heart drug boosted by major clinical trial success
Yahoo/Reuters
Wed, 01/14/15 - 09:03 am
Tags:
AstraZeneca, clinical trials, Brilinta
Next-Generation Diabetes Drug Offers Great Growth Potential
Motley Fool
Sat, 01/10/15 - 01:11 pm
Tags:
diabetes, Novo Nordisk, Perle Biosciences, PRL001, PRL002, JNJ, AstraZeneca, Bristol-Myers Squibb
Pfizer nears a new dawn in oncology with AstraZeneca in the rearview
Fierce Biotech
Fri, 01/9/15 - 08:37 am
Tags:
Pfizer, AstraZeneca, breast cancer, palbociclib
Moderna Therapeutics Raises $450 Million In Biggest Biotech Private Round Ever
Forbes
Mon, 01/5/15 - 04:09 pm
Tags:
Moderna Therapeutics, biotech, IPOs, Alexion, AstraZeneca
Shake-up at AstraZeneca as two immuno-oncology leaders leave
Yahoo/Reuters
Mon, 01/5/15 - 04:02 pm
Tags:
AstraZeneca, immuno-oncology
Grading Pharma In 2014: 17 Drug Companies Ranked
Forbes
Sun, 01/4/15 - 10:23 pm
Tags:
Actavis, Celgene, Amgen, AbbVie, Gilead Sciences, Eli Lilly, Novartis, AstraZeneca, Merck, JNJ, Biogen Idec, Novo Nordisk, Roche, Bristol-Myers Squibb, Pfizer, GSK, Sanofi
4 Potential Blockbuster Drugs The FDA Just Approved
Investors.com
Fri, 12/26/14 - 10:11 pm
Tags:
Bristol-Myers Squibb, Opdivo, Merck, Cubist Pharmaceuticals, Zerbaxa, AstraZeneca, Lynparza, Novo Nordisk, Saxenda
A new era of immuno-oncology has arrived
Fierce Biotech
Fri, 12/26/14 - 10:17 am
Tags:
immuno-oncology, Merck, Keytruda, Bristol-Myers Squibb, Opdivo, Roche, Amgen, AstraZeneca
Big pharma cashes in as M&A fever sweeps sector
FT.com
Fri, 12/26/14 - 09:57 am
Tags:
M&A, Allergan, Actavis, Valeant Pharmaceuticals, AbbVie, Shire, Pfizer, AstraZeneca
AstraZeneca CEO says new Pfizer bid unlikely
Yahoo/Reuters
Mon, 12/22/14 - 09:44 am
Tags:
AstraZeneca, Pharma CEOs, Pfizer, M&A, Pascal Soriot
AstraZeneca's ovarian cancer drug gets U.S. approval
Yahoo/Reuters
Fri, 12/19/14 - 04:01 pm
Tags:
AstraZeneca, Lynparza, ovarian cancer, FDA
The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
Tags:
patents, Lantus, Abilify, Copaxone, Neulasta, Tracleer, Namenda, Avodart, Jalyn, Zyvox, Androgel, Synagis, Sanofi, Bristol-Myers Squibb, Otsuka, Teva Pharmaceutical, Amgen, Actelion, Actavis, GSK, Pfizer, AbbVie, AstraZeneca
AstraZeneca first-in-class ovarian cancer drug wins EU approval
Yahoo/Reuters
Thu, 12/18/14 - 09:01 am
Tags:
AstraZeneca, ovarian cancer, Europe, Lynparza, olaparib
What the AstraZeneca and Ranbaxy Pay-to-Delay Case Didn’t Tell Us
WSJ Pharmalot
Thu, 12/11/14 - 07:27 pm
Tags:
AstraZeneca, Ranbaxy, pay-for-delay, generics
Drug makers face another $65 billion patent cliff
Marketwatch
Wed, 12/10/14 - 05:37 pm
Tags:
patents, patent cliff, Pfizer, Otsuka, AstraZeneca, Bristol-Myers Squibb
Dynavax & AstraZeneca Alter Agreement for Asthma Product
Yahoo/Zacks.com
Tue, 12/9/14 - 10:18 pm
Tags:
asthma, AstraZeneca, Dynavax, AZD1419
AstraZeneca and Ranbaxy Win a Closely Watched Pay-to-Delay Case
WSJ Pharmalot
Mon, 12/8/14 - 12:13 pm
Tags:
AstraZeneca, Ranbaxy, pay-for-delay, Nexium, generics
Will Diabetes Drugs Enter The Anti-Obesity Space?
Seeking Alpha
Mon, 12/8/14 - 08:29 am
Tags:
diabetes, obesity, Arena Pharmaceuticals, Novo Nordisk, AstraZeneca, Orexigen, Vivus, Farxiga, Victoza, Invokana
Will Pfizer End Up Buying Bristol-Myers Squibb As Its Interest In AstraZeneca Fades?
Bidness Etc.
Mon, 12/8/14 - 08:01 am
Tags:
Pfizer, Bristol-Myers Squibb, AstraZeneca, M&A
AstraZeneca's (AZN) Iressa Accepted for Review in the U.S.
Yahoo/Zacks.com
Wed, 12/3/14 - 09:20 pm
Tags:
AstraZeneca, Iressa, FDA, non-small cell lung cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.